Mesoblast (MESO) EBT Growth (3y) (2017 - 2023)
Mesoblast (MESO) EBT Growth (3y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 9.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 40.43% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 12.01% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 86.16% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 15.09% |
| Mar 31, 2023 | -2.69% |
| Dec 31, 2022 | 2.94% |
| Sep 30, 2022 | -31.70% |
| Jun 30, 2022 | 3.46% |
| Mar 31, 2022 | 7.73% |
| Dec 31, 2021 | 1.78% |
| Sep 30, 2021 | -3.96% |
| Jun 30, 2021 | -0.41% |
| Mar 31, 2021 | -2.71% |
| Dec 31, 2020 | -38.52% |
| Sep 30, 2020 | -36.58% |
| Jun 30, 2020 | -4.69% |
| Mar 31, 2020 | -10.17% |
| Dec 31, 2019 | -5.03% |
| Sep 30, 2019 | 31.33% |
| Jun 30, 2019 | 11.27% |
| Mar 31, 2019 | -8.76% |
| Dec 31, 2018 | -7.16% |
| Sep 30, 2018 | -15.37% |